{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:17:31Z","timestamp":1781536651546,"version":"3.54.5"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["MURPHY17I0"],"award-info":[{"award-number":["MURPHY17I0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL143076"],"award-info":[{"award-number":["R01 HL143076"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biofilm"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bioflm.2025.100317","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:31:46Z","timestamp":1758087106000},"page":"100317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Farnesol emulsion for elimination of Pseudomonas aeruginosa biofilm in a 3D airway model of cystic fibrosis"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5780-7521","authenticated-orcid":false,"given":"Li","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khiry","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean V.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioflm.2025.100317_bib1","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.bioflm.2025.100317_bib2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMra1300109","article-title":"Origins of cystic fibrosis lung disease","volume":"372","author":"Stoltz","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bioflm.2025.100317_bib3","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","article-title":"Pathophysiology and management of pulmonary infections in cystic fibrosis","volume":"168","author":"Gibson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bioflm.2025.100317_bib4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ppul.10135","article-title":"Early infection and progression of cystic fibrosis lung disease","volume":"34","author":"Koch","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.bioflm.2025.100317_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.10127","article-title":"Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis","volume":"34","author":"Emerson","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.bioflm.2025.100317_bib7","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2217\/fmb.10.125","article-title":"Pseudomonas aeruginosa biofilms in cystic fibrosis","volume":"5","author":"H\u2298iby","year":"2010","journal-title":"Future Microbiol"},{"key":"10.1016\/j.bioflm.2025.100317_bib8","first-page":"1","article-title":"Pseudomonas aeruginosa biofilms","volume":"vol. 86","author":"Alhede","year":"2014"},{"key":"10.1016\/j.bioflm.2025.100317_bib9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jama.293.5.581","article-title":"Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis","volume":"293","author":"Li","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.bioflm.2025.100317_bib10","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1001\/jama.287.22.2958","article-title":"Respiratory infections with Pseudomonas aeruginosa in children with cystic FibrosisEarly detection by serology and assessment of risk factors","volume":"287","author":"West","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.bioflm.2025.100317_bib11","first-page":"79","article-title":"Eradication of initial Pseudomonas aeruginosa colonization in patients with cystic fibrosis","volume":"7","author":"Griese","year":"2002","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.bioflm.2025.100317_bib12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s40121-022-00591-2","article-title":"Therapeutic strategies for emerging multidrug-resistant Pseudomonas aeruginosa","volume":"11","author":"Kunz","year":"2022","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.bioflm.2025.100317_bib13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bioflm.2025.100317_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011193","article-title":"Architecture and matrix assembly determinants of Bordetella pertussis biofilms on primary human airway epithelium","volume":"19","author":"Fullen","year":"2023","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bioflm.2025.100317_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011559","article-title":"Druggable redox pathways against Mycobacterium abscessus in cystic fibrosis patient-derived airway organoids","volume":"19","author":"Leon-Icaza","year":"2023","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bioflm.2025.100317_bib16","doi-asserted-by":"crossref","first-page":"e02408","DOI":"10.1128\/spectrum.02408-22","article-title":"Evaluating bacterial pathogenesis using a model of human airway organoids infected with Pseudomonas aeruginosa biofilms","volume":"10","author":"Tang","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.bioflm.2025.100317_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s40778-022-00220-1","article-title":"Organoid technologies for SARS-CoV-2 research","volume":"8","author":"Sutton","year":"2022","journal-title":"Curr Stem Cell Rep"},{"key":"10.1016\/j.bioflm.2025.100317_bib18","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bioflm.2025.100317_bib19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41576-018-0051-9","article-title":"Progress and potential in organoid research","volume":"19","author":"Rossi","year":"2018","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.bioflm.2025.100317_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-36863-1","article-title":"Development of a novel air\u2013liquid interface airway tissue equivalent model for in vitro respiratory modeling studies","volume":"13","author":"Leach","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.bioflm.2025.100317_bib21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.aller.2015.05.009","article-title":"Farnesol, a sesquiterpene alcohol in essential oils, ameliorates serum allergic antibody titres and lipid profiles in ovalbumin-challenged mice","volume":"44","author":"Ku","year":"2016","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.bioflm.2025.100317_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.fct.2019.04.037","article-title":"Toxicological and pharmacologic effects of farnesol (C15H26O): a descriptive systematic review","volume":"129","author":"de Ara\u00fajo Delmondes","year":"2019","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.bioflm.2025.100317_bib23","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.fct.2008.06.046","article-title":"Fragrance material review on farnesol","volume":"46","author":"Lapczynski","year":"2008","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.bioflm.2025.100317_bib24","series-title":"Fenaroli's handbook of flavor ingredients","author":"Burdock","year":"2009"},{"key":"10.1016\/j.bioflm.2025.100317_bib25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/08927014.2016.1144053","article-title":"Biofilm formation by Candida albicans and Streptococcus mutans in the presence of farnesol: a quantitative evaluation","volume":"32","author":"Fernandes","year":"2016","journal-title":"Biofouling"},{"key":"10.1016\/j.bioflm.2025.100317_bib26","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1128\/AEM.68.11.5459-5463.2002","article-title":"Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule","volume":"68","author":"Ramage","year":"2002","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.bioflm.2025.100317_bib27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.canlet.2015.02.024","article-title":"Farnesol inhibits tumor growth and enhances the anticancer effects of bortezomib in multiple myeloma xenograft mouse model through the modulation of STAT3 signaling pathway","volume":"360","author":"Lee","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bioflm.2025.100317_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10557-013-6460-2","article-title":"Cardioprotection by farnesol: role of the mevalonate pathway","volume":"27","author":"Sz\u0171cs","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.bioflm.2025.100317_bib29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.foodchem.2013.09.039","article-title":"Hepatoprotection of sesquiterpenoids: a quantitative structure\u2013activity relationship (QSAR) approach","volume":"146","author":"Vinholes","year":"2014","journal-title":"Food Chem"},{"key":"10.1016\/j.bioflm.2025.100317_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax8891","article-title":"PARIS farnesylation prevents neurodegeneration in models of Parkinson's disease","volume":"13","author":"Jo","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bioflm.2025.100317_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106899","article-title":"Synergy with farnesol rejuvenates colistin activity against Colistin-resistant Gram-negative bacteria in vitro and in vivo","volume":"62","author":"Han","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bioflm.2025.100317_bib32","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1203\/PDR.0b013e318232a984","article-title":"Farnesol decreases biofilms of Staphylococcus epidermidis and exhibits synergy with Nafcillin and Vancomycin","volume":"70","author":"Pammi","year":"2011","journal-title":"Pediatr Res"},{"key":"10.1016\/j.bioflm.2025.100317_bib33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jac\/dkl519","article-title":"Sesquiterpene farnesol inhibits recycling of the C55 lipid carrier of the murein monomer precursor contributing to increased susceptibility to \u03b2-lactams in methicillin-resistant Staphylococcus aureus","volume":"59","author":"Kuroda","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bioflm.2025.100317_bib34","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1128\/AAC.50.4.1463-1469.2006","article-title":"Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility","volume":"50","author":"Jabra-Rizk","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2025.100317_bib35","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3390\/antibiotics13040350","article-title":"Repurposing farnesol for combating drug-resistant and persistent single and polymicrobial biofilms","volume":"13","author":"Tan","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.bioflm.2025.100317_bib36","article-title":"Farnesol repurposing for prevention and treatment of Acinetobacter baumannii biofilms","volume":"7","author":"Tan","year":"2024","journal-title":"Biofilms"},{"key":"10.1016\/j.bioflm.2025.100317_bib37","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3390\/antibiotics13080778","article-title":"Farnesol emulsion as an effective broad-spectrum agent against ESKAPE biofilms","volume":"13","author":"Tan","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.bioflm.2025.100317_bib38","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1128\/IAI.71.2.882-890.2003","article-title":"Direct continuous method for monitoring biofilm infection in a mouse model","volume":"71","author":"Kadurugamuwa","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.bioflm.2025.100317_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0167-7012(00)00241-4","article-title":"How to optimize the drop plate method for enumerating bacteria","volume":"44","author":"Herigstad","year":"2001","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.bioflm.2025.100317_bib40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/microorganisms11020363","article-title":"Inhibition of Listeria monocytogenes growth, adherence and invasion in Caco-2 cells by potential probiotic lactic acid bacteria isolated from fecal samples of healthy neonates","volume":"11","author":"Poimenidou","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.bioflm.2025.100317_bib41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00203-022-02889-8","article-title":"Adhesion and aggregation properties of Lactobacillaceae strains as protection ways against enteropathogenic bacteria","volume":"204","author":"Zawistowska-Rojek","year":"2022","journal-title":"Arch Microbiol"},{"key":"10.1016\/j.bioflm.2025.100317_bib42","article-title":"In vitro assay of bacterial adhesion onto Mammalian epithelial cells","volume":"e2783","author":"Letourneau","year":"2011","journal-title":"J Vis Exp"},{"key":"10.1016\/j.bioflm.2025.100317_bib43","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1016\/j.xphs.2016.06.022","article-title":"Efficacy of poly-lactic-co-glycolic acid Micro- and nanoparticles of ciprofloxacin against bacterial biofilms","volume":"105","author":"Thomas","year":"2016","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.bioflm.2025.100317_bib44","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1172\/JCI73469","article-title":"Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure","volume":"124","author":"Henderson","year":"2014","journal-title":"J Clin Investig"},{"key":"10.1016\/j.bioflm.2025.100317_bib45","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1164\/rccm.200607-1011OC","article-title":"MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation","volume":"175","author":"Henke","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bioflm.2025.100317_bib46","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1165\/rcmb.2005-0161OC","article-title":"Long-term cultures of polarized airway epithelial cells from patients with cystic fibrosis","volume":"34","author":"Wiszniewski","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.bioflm.2025.100317_bib47","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0092-8674(00)81724-9","article-title":"Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease","volume":"95","author":"Matsui","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bioflm.2025.100317_bib48","doi-asserted-by":"crossref","first-page":"18825","DOI":"10.1073\/pnas.0904709106","article-title":"Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770","volume":"106","author":"Van Goor","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bioflm.2025.100317_bib49","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1007\/s13346-021-01002-8","article-title":"Testing of aerosolized ciprofloxacin nanocarriers on cystic fibrosis airway cells infected with P. aeruginosa biofilms","volume":"11","author":"Juntke","year":"2021","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.bioflm.2025.100317_bib50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1021\/acsinfecdis.1c00444","article-title":"Transferring microclusters of P. aeruginosa biofilms to the air\u2013liquid interface of bronchial epithelial cells for repeated deposition of aerosolized Tobramycin","volume":"8","author":"Horstmann","year":"2022","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bioflm.2025.100317_bib51","article-title":"P. aeruginosa infected 3D Co-Culture of bronchial epithelial cells and macrophages at air-liquid interface for preclinical evaluation of anti-infectives","volume":"160","author":"Montefusco-Pereira","year":"2020","journal-title":"J Vis Exp"},{"key":"10.1016\/j.bioflm.2025.100317_bib52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1471-2180-12-181","article-title":"Characterization of biofilm-like structures formed by Pseudomonas aeruginosa in a synthetic mucus medium","volume":"12","author":"Haley","year":"2012","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.bioflm.2025.100317_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1023523","article-title":"Pseudomonas aeruginosa reference strains PAO1 and PA14: a genomic, phenotypic, and therapeutic review","volume":"13","author":"Grace","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bioflm.2025.100317_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3476(05)83478-X","article-title":"The changing epidemiology of cystic fibrosis","volume":"122","author":"FitzSimmons","year":"1993","journal-title":"J Pediatr"},{"key":"10.1016\/j.bioflm.2025.100317_bib55","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2958.2005.04941.x","article-title":"Mucin\u2013Pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance","volume":"59","author":"Landry","year":"2006","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.bioflm.2025.100317_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00291-22","article-title":"Effects of Mucin and DNA concentrations in airway mucus on Pseudomonas aeruginosa Biofilm recalcitrance","volume":"7","author":"Rouillard","year":"2022","journal-title":"mSphere"},{"key":"10.1016\/j.bioflm.2025.100317_bib57","doi-asserted-by":"crossref","first-page":"10780","DOI":"10.1073\/pnas.1806005115","article-title":"Entropically driven aggregation of bacteria by host polymers promotes antibiotic tolerance in Pseudomonas aeruginosa","volume":"115","author":"Secor","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bioflm.2025.100317_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002209","article-title":"Pseudomonas aeruginosa type IV pili actively induce mucus contraction to form biofilms in tissue-engineered human airways","volume":"21","author":"Rossy","year":"2023","journal-title":"PLoS Biol"},{"key":"10.1016\/j.bioflm.2025.100317_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2017.00106","article-title":"In vivo and in vitro interactions between Pseudomonas aeruginosa and Staphylococcus spp","volume":"7","author":"Hotterbeekx","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.bioflm.2025.100317_bib60","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/antibiotics10030338","article-title":"Cystic fibrosis: recent insights into inhaled antibiotic treatment and future perspectives","volume":"10","author":"Taccetti","year":"2021","journal-title":"Antibiotics"}],"container-title":["Biofilm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590207525000656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590207525000656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T09:31:20Z","timestamp":1766395880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590207525000656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":59,"alternative-id":["S2590207525000656"],"URL":"https:\/\/doi.org\/10.1016\/j.bioflm.2025.100317","relation":{},"ISSN":["2590-2075"],"issn-type":[{"value":"2590-2075","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Farnesol emulsion for elimination of Pseudomonas aeruginosa biofilm in a 3D airway model of cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Biofilm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioflm.2025.100317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100317"}}